Related Experiment Videos
Oviduct response to glucagon during hysterosalpingography
Radiology
|June 1, 1976
Summary
Glucagon administration successfully induced tubal dilation and spill in 5 out of 9 patients lacking apparent tubal patency on hysterosalpingography. This suggests glucagon
Area of Science:
- Reproductive medicine
- Gynecologic imaging
Background:
- Hysterosalpingography (HSG) is a standard imaging technique to assess female reproductive anatomy.
- Tubal patency is crucial for natural fertility.
- Assessing tubal patency can be challenging in certain cases.
Purpose of the Study:
- To evaluate the efficacy of glucagon in achieving tubal dilation and spill in patients with non-patent fallopian tubes on routine HSG.
- To investigate potential factors influencing glucagon's response.
Main Methods:
- Nine patients with no evidence of tubal patency on initial HSG were administered glucagon.
- Tubal dilation and spill were assessed post-administration.
- Patient history and clinical examination findings were reviewed.
Main Results:
- Five out of nine (55.6%) patients demonstrated tubal dilation and spill after glucagon administration.
- Three of the four non-responders had a history suggestive of pelvic inflammatory disease.
- Side effect data were collected for all participants.
Conclusions:
- Glucagon can facilitate tubal patency in a subset of patients with apparent tubal obstruction on HSG.
- Pelvic inflammatory disease may be associated with a lack of response to glucagon.
- Further research is warranted to explore glucagon's role in fertility assessments.